Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions

Sarah L. Anderson, Matteo Bassetti, Arduino A. Mangoni

Research output: Contribution to journalEditorial

1 Downloads (Pure)

Abstract

The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as well as in vaccine and drug development. Nevertheless, several other advancements in various fields of medicine also deserve attention. Herein, the Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.

Original languageEnglish
Article number10
Number of pages5
JournalDrugs in Context
Volume10
DOIs
Publication statusPublished - Jan 2021

Keywords

  • Antimicrobial resistance
  • Beta-lactams
  • COVID-19
  • Dexamethasone
  • Insulin icodec
  • SGLT2 inhibitors
  • Statin therapy
  • Type 2 diabetes

Fingerprint

Dive into the research topics of 'Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions'. Together they form a unique fingerprint.

Cite this